Related references
Note: Only part of the references are listed.Immune-Responsive Gene 1/Itaconate Activates Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocytes to Protect Against Liver Ischemia-Reperfusion Injury
Zhongjie Yi et al.
HEPATOLOGY (2020)
Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate
Hideo Takahashi et al.
SCIENTIFIC REPORTS (2020)
Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers
Hideo Takahashi et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
ASO Author Reflections: Transitioning From Morphology to Transcriptomics in Capturing Tumor Biology
Hideo Takahashi et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response
Mariko Asaoka et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
ImmuCellAI: A Unique Method for Comprehensive T-Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy
Ya-Ru Miao et al.
ADVANCED SCIENCE (2020)
G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer
Masanori Oshi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer
Yoshihisa Tokumaru et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer
Yoshihisa Tokumaru et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response
Kaitlyn A. Sun et al.
ELIFE (2020)
A Novel 4-gene Score to Predict Survival, Distant Metastasis and Response to Neoadjuvant Therapy in Breast Cancer
Masanori Oshi et al.
CANCERS (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors
Makiko Hayashi et al.
CANCER RESEARCH (2020)
Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma
Eriko Katsuta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer
Shipra Gandhi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation
Yoshihisa Tokumaru et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2-Breast Cancer
Masanori Oshi et al.
CELLS (2020)
CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer
Masanori Oshi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer
Masanori Oshi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Co-administration of sulforaphane and doxorubicin attenuates breast cancer growth by preventing the accumulation of myeloid-derived suppressor cells
Yuan Rong et al.
CANCER LETTERS (2020)
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
Oscar M. Rueda et al.
NATURE (2019)
Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis
Maiko Okano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival
Mariko Asaoka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
Takashi Takeshita et al.
SCIENTIFIC REPORTS (2019)
Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer
Sumana Narayanan et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
NRF2 facilitates breast cancer cell growth via HIF1α-mediated metabolic reprogramming
Hong-Sheng Zhang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Cytolytic Activity (CYT) Score Is a Prognostic Biomarker Reflecting Host Immune Status in Hepatocellular Carcinoma (HCC)
Hiroaki Wakiyama et al.
ANTICANCER RESEARCH (2018)
Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients
Andrew Dodson et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2018)
Clinical Value of RNA Sequencing-Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network-Breast Initiative
Christian Brueffer et al.
JCO PRECISION ONCOLOGY (2018)
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Woosung Chung et al.
NATURE COMMUNICATIONS (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients
Barbara Wolf et al.
BMC CANCER (2016)
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Eri H. Kobayashi et al.
NATURE COMMUNICATIONS (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
H. Bonnefoi et al.
ANNALS OF ONCOLOGY (2014)
Myeloid Lineage-Specific Deletion of Antioxidant System Enhances Tumor Metastasis
Keiichiro Hiramoto et al.
CANCER PREVENTION RESEARCH (2014)
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
Melba C. Jaramillo et al.
GENES & DEVELOPMENT (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
Abena S. Agyeman et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
NRF2 and cancer: the good, the bad and the importance of context
Michael B. Sporn et al.
NATURE REVIEWS CANCER (2012)
Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer
Victor Okoh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2011)
Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
Peeter Karihtala et al.
BMC CANCER (2011)
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Keiko Taguchi et al.
GENES TO CELLS (2011)
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
Christos Hatzis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
When NRF2 Talks, Who's Listening?
Nobunao Wakabayashi et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
Tao Jiang et al.
CANCER RESEARCH (2010)
Nrf2: friend or foe for chemoprevention?
Thomas W. Kensler et al.
CARCINOGENESIS (2010)
Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis
Deepti Malhotra et al.
NUCLEIC ACIDS RESEARCH (2010)
Effect of training-sample size and classification difficulty on the accuracy of genomic predictors
Vlad Popovici et al.
BREAST CANCER RESEARCH (2010)
Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
Shinsuke Homma et al.
CLINICAL CANCER RESEARCH (2009)
Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth
Tsutonm Ohta et al.
CANCER RESEARCH (2008)
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Xiao-Jun Wang et al.
CARCINOGENESIS (2008)
Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer
Tatsuhiro Shibata et al.
GASTROENTEROLOGY (2008)
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
DA Berry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
